Since counterfeit drugs
are generally difficult to detect, reporting on the problem is erratic.
SupplyScape Electronic Pedigree is the first solution to comply with both the federal Prescription Drug Marketing Act (PDMA) and state drug pedigree laws to eradicate counterfeit drugs
, by using the Electronic Product Code (EPC) and RFID industry standards already adopted by the U.
The USFDA defines counterfeit drugs
as a "drug which, or container or labeling of which, without authorization, bears the trademark, trade name, or other identifying mark, imprint, or device, or any likeness thereof, of a manufacturer, processor, packer, or distributor other than the person or persons who in fact manufacture, processed, packed, or distributed such drug and which thereby falsely purports or is represented to be the product, or to have been packed or distributed by, such other drug manufacturer, processor, packer, or distributor.
The protection of human health is paramount to all those concerned in dealing with the serious problem of counterfeit drugs
See WHO FACT SHEET 1, supra note 5 (recognizing growth of counterfeit drug
trade in nations with inadequate supply of desperately needed pharmaceuticals); see also Sick Economy, supra note 7 (noting unsuitable locations where counterfeit drug
trade takes place).
He warned that consumer ordering pharmaceuticals from them might receive counterfeit drugs
with incorrect dosage, false labeling, no pharmaceutical benefit or worse.
Molecular spectroscopic methods are commonly used to detect counterfeit drugs
by determining their chemical structure.
FDA warned that new counterfeit drug
labeled Serostim had been found.
LegitScript President John Horton stated, "A significant majority of Registrars should be commended for prohibiting the use of their platforms in the furtherance of counterfeit drug
and other illicit drug sales.
In a best case scenario, a counterfeit drug
might produce no effects on its users.
Just last fall, Florida and California worked to pass legislation aimed at preventing counterfeit drug
With the pharmaceutical industry experiencing substantial growth in emerging markets, the counterfeit drug
industry has also grown to capture roughly $75 billion of the global drug market.